Psoriasis and mud - bath therapy: Clinical-experimental study;Psoriasi e fangobalneoterapia: Studio clinico sperimentale

Clinica Terapeutica

Volumn 156, Issue 4, 2005, Pages 145-149

  Costantino, Maria ^a,b,c   Lampa, E ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b CERIST Centro Ricerche e Studi Termali   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Mineral water; Mud bath therapy; Psoriasis

Indexed keywords

ANTIPSORIASIS AGENT; BICARBONATE; CHLORINE; MINERAL WATER; SULFUR; ANTIINFLAMMATORY AGENT; CLOBETASOL; CYCLOSPORIN; DERMATOLOGICAL AGENT; DESOXIMETASONE; GLUCOCORTICOID; MOMETASONE FUROATE; PREGNANE DERIVATIVE; RETINOID; VITAMIN D;

ADULT; ARTICLE; BALNEOTHERAPY; CELL KINETICS; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL STUDY; CONTROLLED STUDY; DISEASE SEVERITY; EPIDERMIS; EXPERIMENTAL STUDY; FEMALE; HUMAN; HYPERTHERMIC THERAPY; INTERMETHOD COMPARISON; MALE; MUD THERAPY; PSORIASIS; SYMPTOMATOLOGY; COMPARATIVE STUDY; DRUG COMBINATION; EPIDEMIOLOGY; MIDDLE AGED; OINTMENT; QUALITY OF LIFE; TIME; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS; CLOBETASOL; CYCLOSPORINE; DERMATOLOGIC AGENTS; DESOXIMETASONE; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; MINERAL WATERS; MUD THERAPY; OINTMENTS; PREGNADIENEDIOLS; PSORIASIS; QUALITY OF LIFE; RETINOIDS; SAMPLING STUDIES; TIME FACTORS; TREATMENT OUTCOME; VITAMIN D;

EID: 33644673218     PISSN: 00099074     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Nappi G. Medicina e Clinica Termale. Ed Selecta Medica, Pavia 2001
2. Messina B, Grossi F. Elementi di Idrologia Medica. Ed SEU, Roma 1984
3. Alessi A, Caputo R. Dermatologia e malattie a trasmissione sessuale. Ed. Raffaello Cortina, 1999
4. Baadsgaard O, Fisher G, Voorhees JJ, et al. The role of the immune system in the pathogenesis of psoriasis. J Invest Dermatol 1990;95:32S
5. Lee YA, Ruschendorf F, Windemuth C, et al. Genowide scan in German families reveals evidence for a novel psoriasis-susceptibility locus on chromosome 19p13. Am J Hum Genet 2000; 67/4:1020-24
6. Cheng L, Zhang SZ, Xiao CY, et al. The A5.1 allele of the major histocompatibility complex class I chain-related gene A is associated with psoriasis vulgaris in Chinese. Br J Dermatol 2000;143/2:324-9
7. Capon F, Dalla piccola B, Novelli G. Advances in the search for psoriasis susceptibility genes. Mol Genet Metab 2000;71/1-2:250-5
8. Weigl BA. The significance of stress hormones (glucocorticoids, catecholamines) for eruptions and spontaneous remission phases in psoriasis. Int J Dermatol 2000;39/9:678-88
9. Usuki K, Inoue M, Setoyama M, et al. A case of psoriasis vulgaris triggered by lisinopril. Nishinihon J. Dermatol. 62/4: 461-463, 2000
10. Binderup L, Kragballe K. Razionale d'uso di calcipotriolo nel trattamento della psoriasi. Rev. Contemp Pharmacother 1992;3:357
11. Van Weelden H et al. Therapy of psoriasis: comparison of photochemiotherapy and several variations of phototherapy. Br J Dermatol 1980;103:1
12. Nappi G, Buffoni A, De Luca S, et al. Terapia termale combinata nel trattamento della psoriasi: valutazione dell'efficacia a lungo termine. Med Clin e Term 2003;53-54: 491-504
13. Nappi G, Masciocchi MM, De Luca S, et al. Le muffe termali sulfuree nel trattamento della psoriasi cutanea. Med Clin e Term 1996;34:7-18
14. Frederiksson T, Pettersson U. Severe psoriasis- oral therapy with a new retinoid. Dermatologica 157:238-244, 1978
15. Lison L. Statistica applicata alla biologia sperimentale. Ed Ambrosiana Milano 1989
16. Mian EU: Acquisizioni sperimentali tra dermatologia e medicina termale. In: Terapia idrologia oligometallica. Ed Nicole 1963
17. Tasin L, Urbani F, Recchia G, et al. Fotobalneoterapia a Comando: nuova prospettiva terapeutica per la psoriasi. Riv Med Trent 1985;23:2.
18. Zumiani G, Tasin L, Urbani F, et al. Indagine clinico-statistica sulla terapia idropinica e balneotermale con acque oligominerali delle terme di Comano in soggetti affetti da psoriasi. Min Med 1986;16:627